218 related articles for article (PubMed ID: 1335684)
1. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance.
Majewski S; Jablonska S
Am J Med Sci; 1992 Sep; 304(3):174-9. PubMed ID: 1335684
[TBL] [Abstract][Full Text] [Related]
2. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.
Majewski S; Jabłońska S
Arch Dermatol; 1995 Nov; 131(11):1312-8. PubMed ID: 7503577
[TBL] [Abstract][Full Text] [Related]
3. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
4. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
[TBL] [Abstract][Full Text] [Related]
5. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group.
Boxman IL; Russell A; Mulder LH; Bavinck JN; Schegget JT; Green A
Int J Cancer; 2000 Apr; 86(1):118-21. PubMed ID: 10728604
[TBL] [Abstract][Full Text] [Related]
6. A mouse model for studying epidermodysplasia-verruciformis-associated carcinogenesis.
Majewski S; Breitburd F; Skopinska M; Croissant O; Jablonska S; Orth G
Int J Cancer; 1994 Mar; 56(5):727-30. PubMed ID: 8314350
[TBL] [Abstract][Full Text] [Related]
7. Human papillomaviruses and skin cancer.
Pfister H
Semin Cancer Biol; 1992 Oct; 3(5):263-71. PubMed ID: 1335790
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic potential of human papillomaviruses epidermodysplasia verruciformis: a counterpart of Shope papilloma-carcinoma complex.
Jabłonska S; Orth G; Obalek S; Croissant O; Jarzabek-Chorzelska M; Favre M; Kremsdorf D
Arch Geschwulstforsch; 1983; 53(3):207-15. PubMed ID: 6311135
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 38 isolated from patients with epidermodysplasia verruciformis.
Yutsudo M; Kanda R; Tanigaki T; Kitano Y; Hakura A
Intervirology; 1986; 26(1-2):104-8. PubMed ID: 3032841
[TBL] [Abstract][Full Text] [Related]
10. Epidermodysplasia verruciformis.
Burger B; Itin PH
Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
[TBL] [Abstract][Full Text] [Related]
11. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations?
Majewski S; Jablonska S
Arch Dermatol; 2002 May; 138(5):649-54. PubMed ID: 12020228
[TBL] [Abstract][Full Text] [Related]
12. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis.
Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G
J Invest Dermatol; 2001 Oct; 117(4):935-42. PubMed ID: 11676835
[TBL] [Abstract][Full Text] [Related]
13. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses.
Orth G
Ciba Found Symp; 1986; 120():157-74. PubMed ID: 3013521
[TBL] [Abstract][Full Text] [Related]
14. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion.
Majewski S; Jablonska S
Cancer Res; 1997 Oct; 57(19):4214-6. PubMed ID: 9331078
[TBL] [Abstract][Full Text] [Related]
15. [Papillomavirus and cancer].
Hakura A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2011-21. PubMed ID: 2840032
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
18. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses.
Lutzner MA; Blanchet-Bardon C; Orth G
J Invest Dermatol; 1984 Jul; 83(1 Suppl):18s-25s. PubMed ID: 6330217
[TBL] [Abstract][Full Text] [Related]
19. Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis.
Yutsudo M; Tanigaki T; Kanda R; Sasagawa T; Inoue T; Jing P; Yong-Il H; Hakura A
J Clin Microbiol; 1994 Apr; 32(4):1076-8. PubMed ID: 8027315
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 17 transcripts expressed in skin carcinoma tissue of a patient with epidermodysplasia verruciformis.
Yutsudo M; Hakura A
Int J Cancer; 1987 May; 39(5):586-9. PubMed ID: 3032809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
